168 related articles for article (PubMed ID: 8750444)
21. Hepatic CT enhancement: effect of the rate and volume of contrast medium injection in an animal model.
Garcia P; Genin G; Bret PM; Bonaldi VM; Reinhold C; Atri M
Abdom Imaging; 1999; 24(6):597-603. PubMed ID: 10525816
[TBL] [Abstract][Full Text] [Related]
22. Comparison between one-route and two-route injection for liver and aortic enhancement using MDCT.
Okada M; Murakami T; Kumano S; Imaoka I; Shimono T; Ashikaga R; Hosono M
AJR Am J Roentgenol; 2008 Jun; 190(6):W323-6. PubMed ID: 18492873
[TBL] [Abstract][Full Text] [Related]
23. Simulation of aortic peak enhancement on MDCT using a contrast material flow phantom: feasibility study.
Awai K; Hatcho A; Nakayama Y; Kusunoki S; Liu D; Hatemura M; Funama Y; Denbo M; Sato N; Yamashita Y
AJR Am J Roentgenol; 2006 Feb; 186(2):379-85. PubMed ID: 16423942
[TBL] [Abstract][Full Text] [Related]
24. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate--pharmacokinetic analysis and experimental porcine model.
Bae KT; Heiken JP; Brink JA
Radiology; 1998 Feb; 206(2):455-64. PubMed ID: 9457200
[TBL] [Abstract][Full Text] [Related]
25. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
26. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
[TBL] [Abstract][Full Text] [Related]
27. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
Ma X; Samir AE; Holalkere NS; Sahani DV
AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
[TBL] [Abstract][Full Text] [Related]
28. An optimal contrast dose indicator for the determination of hepatic enhancement in abdominal multidetector computed tomography: comparison of patient attenuation indicator with total body weight and body mass index.
Li J; Udayasankar UK; Tang X; Carew J; Toth TL; Small WC
J Comput Assist Tomogr; 2010; 34(6):874-8. PubMed ID: 21084903
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two contrast materials with different iodine concentrations in enhancing the density of the the aorta, portal vein and liver at multi-detector row CT: a randomized study.
Suzuki H; Oshima H; Shiraki N; Ikeya C; Shibamoto Y
Eur Radiol; 2004 Nov; 14(11):2099-104. PubMed ID: 15309493
[TBL] [Abstract][Full Text] [Related]
30. Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.
Henning T; Weber AW; Bauer JS; Meier R; Carlsen JM; Sutton EJ; Prevrhal S; Ziegler SI; Feussner H; Daldrup-Link HE; Rummeny EJ
Acad Radiol; 2008 Mar; 15(3):342-9. PubMed ID: 18280932
[TBL] [Abstract][Full Text] [Related]
31. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
[TBL] [Abstract][Full Text] [Related]
32. Multi-detector row CT: effect of iodine dose reduction on hepatic and vascular enhancement.
Roos JE; Desbiolles LM; Weishaupt D; Wildermuth S; Hilfiker PR; Marincek B; Boehm T
Rofo; 2004 Apr; 176(4):556-63. PubMed ID: 15088181
[TBL] [Abstract][Full Text] [Related]
33. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
Marincek B; Young SW; Enzmann DR
Invest Radiol; 1982; 17(1):90-4. PubMed ID: 7076441
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of a computer simulated prediction model of contrast enhancement of the liver in spiral CT.
Schöber W; Kopp A; Scherf C; Mehnert F; Heuschmid M; Duda SH; Claussen CD; Pereira P
Eur J Radiol; 2004 Jul; 51(1):19-26. PubMed ID: 15186880
[TBL] [Abstract][Full Text] [Related]
35. Hepatic spiral CT: reduction of dose of intravenous contrast material.
Brink JA; Heiken JP; Forman HP; Sagel SS; Molina PL; Brown PC
Radiology; 1995 Oct; 197(1):83-8. PubMed ID: 7568859
[TBL] [Abstract][Full Text] [Related]
36. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model.
Bae KT; Heiken JP; Brink JA
Radiology; 1998 Jun; 207(3):647-55. PubMed ID: 9609886
[TBL] [Abstract][Full Text] [Related]
37. Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume.
Kondo H; Kanematsu M; Goshima S; Tomita Y; Kim MJ; Moriyama N; Onozuka M; Shiratori Y; Bae KT
Radiology; 2010 Jan; 254(1):163-9. PubMed ID: 20019137
[TBL] [Abstract][Full Text] [Related]
38. Optimization of contrast material administration for electrocardiogram-gated computed tomographic angiography of the chest.
Johnson TR; Nikolaou K; Wintersperger BJ; Fink C; Rist C; Leber AW; Knez A; Reiser MF; Becker CR
J Comput Assist Tomogr; 2007; 31(2):265-71. PubMed ID: 17414765
[TBL] [Abstract][Full Text] [Related]
39. Optimal scan delays for multiphasic renal multidetector row computed tomography performed with fixed injection duration of contrast medium.
Tsuge Y; Kanematsu M; Goshima S; Kondo H; Hoshi H; Yokoyama R; Miyoshi T; Onozuka M; Moriyama N; Bae KT
J Comput Assist Tomogr; 2009; 33(1):101-5. PubMed ID: 19188795
[TBL] [Abstract][Full Text] [Related]
40. Dynamic hepatic CT: uniphasic and biphasic contrast medium injection protocols.
Drop A
Ann Univ Mariae Curie Sklodowska Med; 1999; 54():195-204. PubMed ID: 11205764
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
